PATENT CLAIM ANALYSIS

Application Number: 16132076
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["702", "019000"]

Abstract:
A business method for use in classifying patient samples. The method includes steps of collecting case samples representing a clinical phenotypic state and control samples representing patients without said clinical phenotypic state. Preferably the system uses a mass spectrometry platform system to identify patterns of polypeptides in said case samples and in the control samples without regard to the specific identity of at least some of said polypeptides. Based on identified representative patterns of the state, the business method provides for the marketing of diagnostic products using representative patterns. The present invention relates to systems and methods for identifying new markers, diagnosing patients with a biological state of interest, and marketing/commercializing such diagnostics. The present invention relates to systems and methods of greater sensitivity, specificity, and/or cost effectiveness.

Claim (Index 22):
The method of  claim 21 , wherein said plasma microparticles comprise a subset of proteins present in said plasma sample of said subject.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.87838
- Patent Class: 702.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11178262', '12172988', '11541380', '12799576', '11302605']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.2329878738451731
- 35 USC 102 Novelty (BERT): 0.5296680222490824
- Combined Prediction Score: 0.262655888685564
- Mean Citation Score: 263.741896
- Max Citation Score: 366.3362
- Similarity Product: 269.6127880785823

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test